Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Mar 14, 2005; 11(10): 1452-1456
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1452
Published online Mar 14, 2005. doi: 10.3748/wjg.v11.i10.1452
Dose | Survival fraction of HepG2 and Hep3b | |||||||
Modeling EBRT-03’ | Modeling IMRT-15’ | Modeling IMRT-30’ | Modeling IMRT-45’ | |||||
HepG2 | Hep3b | HepG2 | Hep3b | HepG2 | Hep3b | HepG2 | Hep3b | |
0.0 Gy | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
1.0 Gy×1 | 0.87 | 0.48 | 0.88 | 0.48 | 0.88 | 0.48 | 0.91 | 0.48 |
2.0 Gy×1 | 0.6636 | 0.3559 | 0.6747 | 0.4123 | 0.7012 | 0.4389 | 0.7133 | 0.45 |
2.0 Gy×2 | 0.4669 | 0.0507 | 0.5123 | 0.0546 | 0.5181 | 0.055 | 0.5498 | 0.059 |
2.0 Gy×3 | 0.2578 | 0.055 | 0.2906 | 0.02 | 0.3006 | 0.0208 | 0.3236 | 0.023 |
2.0 Gy×4 | 0.1321 | 0.0027 | 0.17 | 0.0033 | 0.1987 | 0.0049 | 0.2137 | 0.0051 |
2.0 Gy×5 | 0.0547 | 0.0005 | 0.0671 | 0.0007 | 0.0851 | 0.0009 | 0.0996 | 0.0011 |
- Citation: Zheng XK, Chen LH, Yan X, Wang HM. Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing. World J Gastroenterol 2005; 11(10): 1452-1456
- URL: https://www.wjgnet.com/1007-9327/full/v11/i10/1452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i10.1452